{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:06:33Z","timestamp":1785564393430,"version":"3.56.0"},"reference-count":34,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:00:00Z","timestamp":1219881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To assess the extent to which patients with type 1 Gaucher disease (GD1) receiving individualized enzyme replacement therapy with imiglucerase attain six defined therapeutic goals. One hundred and ninety\u2010five GD1 patients enrolled in the ICGG Gaucher Registry, all of whom had data available for hemoglobin, platelet count, liver volume, spleen volume, bone pain, and bone crises at first infusion and after 4 years of therapy with imiglucerase, were evaluated for achievement of published therapeutic goals. The proportion of patients who met all six therapeutic goals increased from 2.1% at first infusion to 41.5% at 4 years; \u22655 goals from 12.8% to 76.9%; \u22654 goals from 37.4% to 92.8%; \u22653 goals from 70.8% to 99.0%; and \u22652 goals from 95.4% to 99.5%. All patients met at least one goal at first infusion and after 4 years of treatment. The proportion of patients meeting specific therapeutic goals increased for all parameters between first infusion and 4 years of therapy: platelet count (24.6%\u201379.5%), spleen volume (25.6%\u201378.5%), liver volume (45.6%\u201390.8%), bone pain (62.6\u201370.3%), hemoglobin (68.2\u201391.8%), and bone crises (91.8\u201399.0%). On average, patients who received higher doses of imiglucerase achieved a greater number of therapeutic goals. This analysis provides a benchmark for evaluating the utility of a disease management approach for GD1 based on monitoring achievement of therapeutic goals after treatment with imiglucerase. Am. J. Hematol. 83:890\u2013895, 2008. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.21280","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T17:03:12Z","timestamp":1219942992000},"page":"890-895","source":"Crossref","is-referenced-by-count":69,"title":["A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase"],"prefix":"10.1002","volume":"83","author":[{"given":"Neal","family":"Weinreb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"vom Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,25]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2835"},{"key":"e_1_2_1_3_2","volume-title":"The Online Metabolic and Molecular Basis of Inherited Metabolic Disease","author":"Grabowski G","year":"2006"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000042983.60840.f3"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hch036"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005655031239"},{"key":"e_1_2_1_7_2","first-page":"3635","volume-title":"The Online Metabolic & Molecular Bases of Inherited Disease","author":"Beutler E","year":"2006"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199211000-00002"},{"key":"e_1_2_1_9_2","first-page":"177","volume-title":"Gaucher Disease: A Century of Delineation and Research","author":"Lee RE","year":"1982"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20908"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01150-6"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.07.010"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025902113005"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-7-200604040-00005"},{"key":"e_1_2_1_15_2","unstructured":"HuntSA AbrahamWT ChinMH et al. ACC\/AHA2005guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation andManagement of Heart Failure). American College of Cardiology Web Site. Available at:http:\/\/www.acc.org\/clinical\/guidelines\/failure\/\/index.pdf."},{"key":"e_1_2_1_16_2","volume-title":"Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. Clinical Guideline 5","author":"National Institute for Clinical Excellence","year":"2003"},{"issue":"2","key":"e_1_2_1_17_2","first-page":"S32","article-title":"Strategies to improve the use of evidence\u2010based heart failure therapies","volume":"6","author":"Fonarow GC","year":"2005","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"e_1_2_1_18_2","first-page":"S1","article-title":"Clinical practice recommendations 2000","volume":"23","author":"American Diabetes Association","year":"2000","journal-title":"Diabetes Care"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.07.009"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.suppl_1.S4"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01847.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.HCR.0000270695.94010.c2"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.09.003"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4308"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.08.027"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080702"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.4.237"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4672"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.03.004"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.08.004"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20973"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x"},{"key":"e_1_2_1_34_2","first-page":"20a","article-title":"Clinical factors influencing the achievement of a complete response after 24 months of enzyme replacement therapy in patients with Gaucher disease: the Gaucher Registry","volume":"98","author":"Weinreb N","year":"2001","journal-title":"Blood"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.7863\/jum.1997.16.3.209"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.21280","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.21280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:42:18Z","timestamp":1699972938000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.21280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,25]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1002\/ajh.21280"],"URL":"https:\/\/doi.org\/10.1002\/ajh.21280","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,25]]}}}